ï»¿<body>
	<style type="text/css">
		.cs5AD36D8A{text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:2}
		.csE736517A{color:#000000;background-color:transparent;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;}
		.cs45E53620{text-align:justify;text-indent:36pt;margin:0pt 0pt 0pt 0pt;line-height:2}
		.cs9C2147B1{text-align:justify;text-indent:36pt;margin:0pt 0pt 8pt 0pt;line-height:2}
		.cs6D9F0C8B{color:#000000;background-color:transparent;font-family:Arial;font-size:11pt;font-weight:bold;font-style:normal;}
	</style>
	<p class="cs5AD36D8A"><span class="csE736517A">HB3343 H HHR AMT</span></p><p class="cs5AD36D8A"><span class="csE736517A">Sargent 3380</span></p><p class="cs5AD36D8A"><span class="csE736517A">&nbsp;</span></p><p class="cs45E53620"><span class="csE736517A">The Committee on Health and Human Resources moved to amend the bill by striking out the title and substituting therefor a new title, to read as follows:</span></p><p class="cs9C2147B1"><span class="cs6D9F0C8B">Com. Sub. for H. B. 3343 </span><span class="csE736517A">-- A Bill to amend and reenact &sect;60A-2-204 of the Code of West Virginia, 1931, as amended, relating to schedule I drugs; and adding a provision relating to the scheduling of an organic psilocybin substance or crystalline polymorph psilocybin approved by the Food and Drug Administration and the Drug Enforcement Administration&rdquo;;</span></p><p class="cs45E53620"><span class="csE736517A">&nbsp;</span></p><p class="cs45E53620"><span class="csE736517A">&nbsp;</span></p><p class="cs45E53620"><span class="csE736517A">&nbsp;</span></p><p class="cs45E53620"><span class="csE736517A">&nbsp;</span></p><p class="cs5AD36D8A"><span class="csE736517A">Adopted</span></p><p class="cs5AD36D8A"><span class="csE736517A">Rejected</span></p><p class="cs5AD36D8A"><span class="csE736517A">&nbsp;</span></p></body>
